Roche says U.S. FDA issues Emergency Use Authorization for Zika test

August 29, 2016 1:28 AM EDT

Roche tablets are seen positioned in front of a displayed Roche logo in this photo illustration shot January 22, 2016. REUTERS/Dado Ruvic/Illustration/File Photo

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

ZURICH (Reuters) - Swiss drugmaker Roche (NYSE: ROG) said on Monday the U.S. Food and Drug Administration (FDA) had issued an Emergency Use Authorization (EUA) for its test for the Zika virus.

"The LightMix Zika test is an easy-to-use molecular diagnostic test that enables healthcare professionals to quickly detect the virus," said Uwe Oberlaender, the head of molecular diagnostics at Basel-based Roche.

The virus has been associated with microcephaly, a birth defect characterized by an unusually small head and potential developmental problems.

(Reporting by Joshua Franklin; Editing by Subhranshu Sahu)

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment